Stay updated with breaking news from 46433010. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Arizona State Retirement System boosted its stake in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Get Rating) by 3.9% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 36,047 shares of the company’s stock after acquiring an additional 1,367 shares during the quarter. […]
VNET Group restated their maintains rating on shares of Ionis Pharmaceuticals (NASDAQ:IONS – Get Rating) in a research note released on Thursday, Benzinga reports. IONS has been the subject of several other research reports. Citigroup raised Ionis Pharmaceuticals from a sell rating to a neutral rating and raised their price target for the stock from […]
Citigroup upgraded shares of Ionis Pharmaceuticals (NASDAQ:IONS – Get Rating) from a sell rating to a neutral rating in a research report released on Thursday morning, The Fly reports. The firm currently has $36.00 price objective on the stock, up from their previous price objective of $30.00. A number of other brokerages also recently weighed […]
Ionis Pharmaceuticals (NASDAQ:IONS – Get Rating)‘s stock had its “maintains” rating reaffirmed by investment analysts at VNET Group in a report issued on Thursday, Benzinga reports. Several other equities analysts have also weighed in on the company. SVB Securities cut their target price on Ionis Pharmaceuticals from $34.00 to $27.00 in a report on Thursday, […]
Ionis Pharmaceuticals (NASDAQ:IONS – Get Rating) posted its quarterly earnings data on Wednesday. The company reported ($0.87) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($1.00) by $0.13, Briefing.com reports. Ionis Pharmaceuticals had a negative net margin of 45.75% and a negative return on equity of 43.01%. The company had revenue […]